GP-C8, 3 µm - Reversed Phase

Cat. No.	Description	Specification	Unit	Price
CC02501786-01	Guard Column	GP-C8 (3 µm, 120 Å), 4.6×50mm	Each	Inquiry
CC02501786-02		GP-C8 (3 µm, 120 Å), 4.6×150mm	Each	Inquiry
CC02501786-03		GP-C8 (3 µm, 120 Å), 4.6×250mm	Each	Inquiry
CC02501786-04	Custom Column, Guard Cartridge only	GP-C8 (3 µm, 120 Å), 2.0×10mm	Each	Inquiry
CC02501786-05	Custom Column, Guard Cartridge with holder	GP-C8 (3 µm, 120 Å), 2.0×10mm	Each	Inquiry
CC02501786-06	Custom Column	GP-C8 (3 µm, 120 Å), 2.1×30mm	Each	Inquiry
CC02501786-07	Custom Column, Guard Column	GP-C8 (3 µm, 120 Å), 2.1×50mm	Each	Inquiry
CC02501786-08	Custom Column	GP-C8 (3 µm, 120 Å), 2.1×150mm	Each	Inquiry
CC02501786-09	Custom Column	GP-C8 (3 µm, 120 Å), 2.1×250mm	Each	Inquiry
CC02501786-10	Custom Column, Guard Cartridge only	GP-C8 (3 µm, 120 Å), 4.0×10mm	Each	Inquiry
CC02501786-11	Custom Column, Guard Cartridge with holder	GP-C8 (3 µm, 120 Å), 4.0×10mm	Each	Inquiry

Product Description

Product Description

GP-C8 phase is synthesized with monomeric and fully endcapped chemistry. The uniform octyl stationary phase allows high efficiency with lower hydrophobicity compared to ODS phase. GP-C8 phase is suitable for separating compounds with a wide range of hydrophobicity. It is highly recommended for separating the compounds which are too strongly retained on C18 phases.

Features

• Highly controlled chemistry of monolayer formation and end-capping
• Extremely high column-to-column reproducibility
• High selectivity and efficiency for separations
• Full coverage bonded silica packing to achieve the exceptionally high stability
• Suitable for separations of acidic, neutral and basic organic compounds, such as pharmaceuticals, peptides, and organic acids

Specifications

Silica: Sperical, high purity (<10 ppm metals)
Pore size: 120 Å
Particle size: 3, 5, and 10 µm
Pore volume: 1.0 ml/g
Surface area: 300 m²/g
Phase structure: Monomeric and fully endcapped
% Carbon: 11.0%